Lemonade, Inc. (LMND) - Episode 129 - Nov 5, 2025

💥 Is a Blockbuster Earnings Report Enough to Beat the Bears? 💥 On this episode of D-Risk, we're squeezing the data on insurance disruptor Lemonade ($LMND). They just delivered a stellar quarter, crushing revenue and raising guidance—the kind of news that should send a stock soaring. But with Wall Street analysts still lukewarm and a massive 28% of the company's float sold short, the sentiment is overwhelmingly skeptical. We dive into the contradictory technical signals and options market battle lines to determine if this fundamental catalyst is a genuine turning point for a higher valuation or just a short-term sugar rush before a crash. Press play to find out the full strategic outlook!